Haleon Pakistan Limited (PSX: HALEON) has reported an exceptional financial performance for the year ended December 31, 2025, with net profit surging 39% to Rs6.37 billion, up from Rs4.58 billion in the previous year. The strong results were accompanied by a shareholder-friendly dividend declaration of Rs15 per share, rewarding investors for the company’s robust performance.
Read More: CCP Urges Major Reforms to Boost Competition in Pakistan’s Auto Sector
Earnings per share (EPS) grew proportionately, reaching Rs54.45 compared to Rs39.11 in the corresponding period last year, representing a 39% increase in shareholder returns. The stellar bottom-line growth was driven by robust sales, significant gross margin expansion, and effective cost management across the organization.
Strong Revenue Growth Drives Performance
Haleon’s net revenue from contracts with customers grew by a solid 16% year-on-year to Rs43.11 billion from Rs37.21 billion. This top-line expansion reflects strong demand for the company’s consumer healthcare products and effective execution of its market strategy. The revenue growth was broad-based, supported by the company’s portfolio of trusted brands and its extensive distribution network across Pakistan.
Crucially, the company demonstrated excellent cost absorption capabilities. The cost of sales increased by only 8% to Rs26.25 billion from Rs24.39 billion. Because top-line growth vastly outpaced the rise in direct costs, gross profit jumped 31% to Rs16.85 billion from Rs12.82 billion. Consequently, the gross profit margin expanded handsomely to 39.1% from 34.4% in the previous year, highlighting the company’s pricing power and operational efficiency.
Operating Expenses Remain Well Managed
On the operating side, overheads remained largely in check relative to sales growth, demonstrating disciplined financial management. Selling, marketing, and distribution expenses rose 9% to Rs5.18 billion, while administrative expenses also grew by 9% to Rs864.51 million. These increases were significantly below the rate of revenue growth, contributing to operating leverage.
While other expenses spiked 41% to Rs907.79 million and other income dropped 27% to Rs785.57 million, the sheer strength of the gross profit pushed operating profit up by 38% to Rs10.68 billion from Rs7.71 billion. This demonstrates the resilience of Haleon’s core business model and its ability to absorb variances in non-core income and expense items.
Financial Charges Plunge, Boosting Bottom Line
Below the operating line, the company achieved massive savings as financial charges plummeted 70% to just Rs22.39 million from Rs75.22 million in the prior year. This significant reduction in finance costs reflects improved cash flow management, lower borrowing requirements, and potentially favorable interest rate dynamics during the period.
Despite a sharp increase in levies, which rose to Rs33.11 million, profit before income taxes grew 39% to Rs10.63 billion from Rs7.63 billion. The company booked a heavier net taxation expense of Rs4.25 billion, up 39% year-on-year, reflecting the higher profitability. However, the strong operational performance seamlessly absorbed this increased tax burden, leaving the final profit after tax at a robust Rs6.37 billion.
Shareholder Rewards Through Dividend
In recognition of the strong financial performance and the company’s commitment to delivering value to its investors, the Board of Directors declared a cash dividend of Rs15 per share. This dividend payout rewards shareholders for their confidence in the company and reflects Haleon’s robust cash generation capabilities and healthy balance sheet.
The dividend declaration is particularly significant given the challenging economic environment and demonstrates the company’s confidence in its future prospects. For income-focused investors, the Rs15 per share dividend provides attractive returns and reinforces Haleon’s position as a reliable dividend-paying stock on the Pakistan Stock Exchange.
Strategic Implications
Haleon’s stellar performance in CY2025 underscores the strength of its brand portfolio, the effectiveness of its market strategy, and the resilience of the consumer healthcare sector in Pakistan. The company has successfully navigated economic headwinds to deliver double-digit growth across key financial metrics while simultaneously rewarding shareholders.
The 39% gross margin achieved during the year represents a significant improvement and positions the company favorably for future growth. With strong brand equity, extensive distribution reach, and disciplined financial management, Haleon appears well-positioned to sustain its growth trajectory in the coming years.
About Haleon Pakistan Limited
Haleon Pakistan Limited (PSX: HALEON) is a leading consumer healthcare company, offering a portfolio of trusted brands in categories including oral health, pain relief, respiratory health, and digestive health. The company is committed to delivering everyday health solutions that improve the well-being of Pakistani consumers.
